CAMOTESKIMAB
UNII ONX021SC9O

Substance Identification & Data

This profile provides standardized clinical and technical data for Camoteskimab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) ONX021SC9O.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2492472-82-7 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

ONX021SC9O

CAS Registry Number

2492472-82-7

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

CAMOTESKIMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C179215

National Cancer Institute reference terminology for clinical and research data.

INN ID

12062

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Camoteskimab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

CAMOTESKIMAB

Common Names & Synonyms

CAMOTESKIMAB [INN]

CAMOTESKIMAB [WHO-DD]

IMMUNOGLOBULIN G1 (242-PHENYLALANINE,243-GLUTAMIC ACID,339-SERINE), ANTI-(HUMAN INTERLEUKIN 18) (HUMAN MONOCLONAL CERC-007 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL CERC-007 .KAPPA.-CHAIN, DIMER